hotspot -WSS

hotspot

author：fashion 2025-09-28 20:05:12 - browse：5337

Joe Biden in 2016. -- first opinion coverage from STAT — President Joe Biden Elise Amendola/AP

WASHINGTON — The latest phase of President Biden’s Cancer Moonshot initiative leaves open a few questions on how Congress might move forward with the program.

Since its launch in 2016, the federally funded cancer moonshot program has spurred thousands of scientific publications, 49 clinical trials, and more than 30 patent filings, according to a new report from the Congressional Research Service, the nonpartisan research arm of Congress.

The next phase of the cancer moonshot, according to Biden and his administration, is meant to emphasize cancer screening, prevention, and equitable treatment. The updated plan also seeks to speed progress on treatments for rare and childhood cancers, and it calls for supporting patients, survivors, and caregivers. The Advanced Research Projects Agency for Health (ARPA-H), a new agency tasked with taking big risks on biomedical and health technology, is also committing $240 million to cancer-related research and investing in new data-sharing platforms and a nationwide network for clinical trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Experimental asthma app from Apple and Anthem shows promise

hotspot

WSS

Ohio still needs to do more to protect the right to abortion

Will the market for weight loss drugs really reach $100 billion?

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Ohio still needs to do more to protect the right to abortion

What to do when lifesaving products contribute to climate change

hotspot

hotspot

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Sports medicine is finally prioritizing gender equality

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Walensky prepares to leave CDC — and Congress — behind

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Weight loss drugs should be covered by insurers, AMA says

BioMarin wins approval for gene therapy to treat hemophilia A

Weight loss drugs should be covered by insurers, AMA says

hotspot

What to do when lifesaving products contribute to climate change

The EPA's new lead rule: How one expert crunched the numbers

As biotech industry slumps, bioscience job market is upside down

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

What don’t we know about an Alzheimer’s drug side effect?

FDA reorg will put new emphasis on investigations, sources say

focus

hotspot

hotspot

explore